2015 Quality Performance Results Table

Measure Number Measure Name 2015 reporting period
ACO performance rate Mean performance rate (SSP- ACOs)
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information  85 81
ACO-2 CAHPS: How Well Your Providers Communicate  94 93
ACO-3 CAHPS: Patients’ Rating of Provider  95 92
ACO-4 CAHPS: Access to Specialists  86 84
ACO-5 CAHPS: Health Promotion and Education 56 59
ACO-6 CAHPS: Shared Decision Making  77 75
ACO-7 CAHPS: Health Status/Functional Status  72 72
ACO-34 CAHPS: Stewardship of Patient Resources* 38 27
ACO-8 Risk Standardized, All Condition Readmission 14.68 14.86
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)* 17.83 18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes* 49.37 54.60
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure* 71.64 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 64.87 62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 1.14 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 1.10 1.04
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 99% 76%
ACO-39 Documentation of Current Medications in the Medical Record* 60% 84%
ACO-13 Falls: Screening for Future Fall Risk  61% 56%
ACO-14 Preventive Care and Screening: Influenza Immunization 48% 62%
ACO-15 Pneumonia Vaccination Status for Older Adults 50% 64%
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 43% 71%
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 84% 90%
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 18% 45%
ACO-19 Colorectal Cancer Screening 43% 60%
ACO-20 Breast Cancer Screening 62% 66%
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented  35% 70%
ACO-40 Depression Remission at Twelve Months* N/A N/A
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control  31% 20%
ACO-41 Diabetes: Eye Exam* 0% 41%
ACO-28 Hypertension: Controlling High Blood Pressure  69% 70%
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 84% 84%
ACO-31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 91% 87%
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 79% 78%

CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.

*= Measure required beginning Reporting Year 2015.

N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A